These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 30708024)
1. Collateral sensitivity of natural products in drug-resistant cancer cells. Efferth T; Saeed MEM; Kadioglu O; Seo EJ; Shirooie S; Mbaveng AT; Nabavi SM; Kuete V Biotechnol Adv; 2020; 38():107342. PubMed ID: 30708024 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of South-African medicinal plants towards sensitive and multidrug-resistant cancer cells. Saeed MEM; Meyer M; Hussein A; Efferth T J Ethnopharmacol; 2016 Jun; 186():209-223. PubMed ID: 27058630 [TBL] [Abstract][Full Text] [Related]
3. Identification of Gedunin from a Phytochemical Depository as a Novel Multidrug Resistance-Bypassing Tubulin Inhibitor of Cancer Cells. Khalid SA; Dawood M; Boulos JC; Wasfi M; Drif A; Bahramimehr F; Shahhamzehei N; Shan L; Efferth T Molecules; 2022 Sep; 27(18):. PubMed ID: 36144591 [TBL] [Abstract][Full Text] [Related]
4. Marine Natural Products as Models to Circumvent Multidrug Resistance. Long S; Sousa E; Kijjoa A; Pinto MM Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665 [TBL] [Abstract][Full Text] [Related]
5. Exploiting the metabolic energy demands of drug efflux pumps provides a strategy to overcome multidrug resistance in cancer. Gao X; Aguanno D; Board M; Callaghan R Biochim Biophys Acta Gen Subj; 2021 Aug; 1865(8):129915. PubMed ID: 33965440 [TBL] [Abstract][Full Text] [Related]
6. MRP1-dependent Collateral Sensitivity of Multidrug-resistant Cancer Cells: Identifying Selective Modulators Inducing Cellular Glutathione Depletion. Lorendeau D; Dury L; Nasr R; Boumendjel A; Teodori E; Gutschow M; Falson P; Di Pietro A; Baubichon-Cortay H Curr Med Chem; 2017; 24(12):1186-1213. PubMed ID: 27855620 [TBL] [Abstract][Full Text] [Related]
7. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux. Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445 [TBL] [Abstract][Full Text] [Related]
8. Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines. Jensen PB; Christensen IJ; Sehested M; Hansen HH; Vindeløv L Br J Cancer; 1993 Feb; 67(2):311-20. PubMed ID: 8094293 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines. Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210 [TBL] [Abstract][Full Text] [Related]
10. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance. Karthikeyan S; Hoti SL Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Saeed M; Kuete V; Kadioglu O; Börtzler J; Khalid H; Greten HJ; Efferth T Phytomedicine; 2014 Oct; 21(12):1525-33. PubMed ID: 25442261 [TBL] [Abstract][Full Text] [Related]
12. Prediction of broad spectrum resistance of tumors towards anticancer drugs. Efferth T; Konkimalla VB; Wang YF; Sauerbrey A; Meinhardt S; Zintl F; Mattern J; Volm M Clin Cancer Res; 2008 Apr; 14(8):2405-12. PubMed ID: 18413831 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds. Gruber L; Abdelfatah S; Fröhlich T; Reiter C; Klein V; Tsogoeva SB; Efferth T Molecules; 2018 Apr; 23(4):. PubMed ID: 29642419 [TBL] [Abstract][Full Text] [Related]
14. Comparison between tumors in plants and human beings: Mechanisms of tumor development and therapy with secondary plant metabolites. Ullrich CI; Aloni R; Saeed MEM; Ullrich W; Efferth T Phytomedicine; 2019 Nov; 64():153081. PubMed ID: 31568956 [TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Pérez-Tomás R Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198 [TBL] [Abstract][Full Text] [Related]